Background and purpose: To investigate the SPARC expression and relationship with survival in Colorectal cancer (CRC) patients in Han, Buyi and Miao race. Methods: In our study, SPARC protein expression was detected in 90 available formalin-fixed paraffin-embedded (FFPE) tissues specimens from CRC patients in Han, Buyi and Miao race from the Third Affiliated Hospital of Guizhou Medical University by means of immunohistochemistry. According to the different expression of SPARC, the patients were divided into low expression group (SPARC score of 0+and 1+) and high expression group (SPARC score of 2+ and 3+). The correlations between the two groups in DFS and OS were analyzed, respectively. Results: SPARC was mainly expressed in tumor cell cytoplasm and the positive rates of SPARC was 52.2% (47/90). There was no difference in the positive expression rate in the Han, Buyi and Miao race (P =0.87). SPARC expression was related to the pathological type (Adenocarcinoma). There was a marked associations in DFS between the low expression of SPARC group and high expression group (P=0.048, 0.047) in the Han and Miao ethnic. While the same result was no found in the Buyi race (P=0.176). There was no statistical significance in OS between the low expression of SPARC group and high expression group in the Buyi, Miao and Han race, respectively(P= 0.338, 0.424, 0.282). Conclusion: SPARC was related with DFS in the Miao and Han race, while no correlation in the Buyi race.
Introduction olorectal cancer is one of the third most common malignant tumor, and it is the fourth leading cause of cancer-related deaths in the world [1, 2] . In the past few years, the incidence and mortality rates of CRC continuously rise. SPARC, also known as bone adhesion protein and basal membrane-40 protein, is a member of the extracellular matrix protein family [3] . The expression of SPARC was first identified in bone and endothelial cells played roles in the development and differentiation of chondrocytes and megakaryocytes [4, 5] . SPARC has a wide range of biological effects [6] . SPARC is also expressed in many advanced cancers. Recently, the up-regulated expression of SPARC was associated with gastric cancer, esophageal cancer and CRC [5, 7, 8] , and this high levels of SPARC have been shown to be associated with poor prognosis in gastric cancer [8] .
SPARC protein directly affects cell adhesion, migration, proliferation, and the formation of blood vessels, plays an important role in the process of the occurrence and development of CRC, and is associated with prognosis in patients [9] . But the different expression level in different race groups
have not yet reported. There is no studied about the 
Materials and methods
The study examined cases from 101 patients Streptavidin peroxidase (S-P) IHC staining was performed using SPARC antibody of mouse monoclonal (diluted 1/200). The detailed procedures were done as described by Jennbacken [10] . PBS was used to replace the primary antibody in negative controls. According to our data and TMA IHC grading method by Serrero G [11] and Pan [12] , our scoring was semi quantitatively categorized as: ≤5% of tumor cells staining with/without weakly stained was negative (0), followed by a score of 1 (>5% of tumor cells and with weak/focal positive staining or ≤5% of tumor cells with strongly stained), 2 (>5% of tumor cells and with moderate/focal positive staining), 3(>5% of tumor cells and with strong/diffuse positive staining).
Statistical analysis
The correlation between SPARC, clinical- Time to recurrence (local, regional and distant) was censored at time of last disease-free follow-up, and at death for those patients who died without a previous recurrence [13] . Statistical significance was defined as P value<0.05. SPSS17.0 software package was used for all statistical analyses.
Results
According to the Immunohistochemical results that There was no difference in the positive expression rate in the Han, Buyi and Miao race (P =0.87). (Table   1 ). 
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